Do cyclo-oxygenase 2 inhibitors increase the risk of cardiovascular events?
Nat Clin Pract Oncol
.
2005 Sep;2(9):434-5.
doi: 10.1038/ncponc0291.
Authors
Andrew T Chan
1
,
Charles S Fuchs
Affiliation
1
Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02116, USA. achan@partners.org
PMID:
16265007
DOI:
10.1038/ncponc0291
No abstract available